FXH holdings
All 78 positions of First Trust Health Care AlphaDEX Fund.
Positions
78
Top 10 weight
25.6%
Effective holdings
58.2
1 / sum of squared weights
In stocks
100.0%
In bonds
0.0%
Outside the US
4.4%
Asset mix
Sectors
96% of stocks classifiedCountries
Holdings
| # | Holding | Type | Weight | Value | Shares / par | Country |
|---|---|---|---|---|---|---|
| 1 | OGNOrganon & Co. | Equity | 3.83% | $33M | 2,527,212 | US |
| 2 | HUMHumana Inc. | Equity | 2.95% | $26M | 109,132 | US |
| 3 | ELVElevance Health, Inc. | Equity | 2.78% | $24M | 64,637 | US |
| 4 | MOHMolina Healthcare, Inc. | Equity | 2.53% | $22M | 113,564 | US |
| 5 | CIThe Cigna Group | Equity | 2.36% | $21M | 70,938 | US |
| 6 | GMEDGLOBUS MEDICAL INC | Equity | 2.27% | $20M | 219,621 | US |
| 7 | EXELExelixis Inc | Equity | 2.24% | $20M | 441,186 | US |
| 8 | BIIBBiogen Inc. Common Stock | Equity | 2.23% | $20M | 103,216 | US |
| 9 | SOLVSolventum Corporation | Equity | 2.23% | $20M | 289,778 | US |
| 10 | INCYIncyte Genomics Inc | Equity | 2.19% | $19M | 201,047 | US |
| 11 | DVADaVita Inc. | Equity | 2.19% | $19M | 123,121 | US |
| 12 | BIOBio-Rad Laboratories, Inc.Class A | Equity | 2.18% | $19M | 67,883 | US |
| 13 | UHSUniversal Health Services, Inc. Class B | Equity | 2.04% | $18M | 105,730 | US |
| 14 | HCAHCA Healthcare, Inc. | Equity | 1.99% | $17M | 39,985 | US |
| 15 | REGNRegeneron Pharmaceuticals Inc | Equity | 1.98% | $17M | 24,491 | US |
| 16 | CAHCardinal Health, Inc. | Equity | 1.98% | $17M | 89,549 | US |
| 17 | ZBHZimmer Biomet Holdings, Inc. | Equity | 1.97% | $17M | 209,273 | US |
| 18 | CHEChemed Corporation | Equity | 1.95% | $17M | 40,076 | US |
| 19 | EHCEncompass Health Corporation Common Stock | Equity | 1.79% | $16M | 156,498 | US |
| 20 | CORCencora, Inc. | Equity | 1.74% | $15M | 85,107 | US |
| 21 | IONSIonis Pharmaceuticals, Inc. Common Stock | Equity | 1.72% | $15M | 201,598 | US |
| 22 | PENPenumbra, Inc. | Equity | 1.72% | $15M | 46,100 | US |
| 23 | AMGNAmgen Inc | Equity | 1.70% | $15M | 43,025 | US |
| 24 | UTHRUnited Therapeutics Corp | Equity | 1.67% | $15M | 25,529 | US |
| 25 | PFEPfizer Inc. | Equity | 1.65% | $14M | 539,103 | US |
| 26 | BDXBecton, Dickinson and Co. | Equity | 1.64% | $14M | 96,279 | US |
| 27 | THCTenet Healthcare Corporation New | Equity | 1.63% | $14M | 80,219 | US |
| 28 | MRKMerck & Co., Inc. | Equity | 1.57% | $14M | 125,846 | US |
| 29 | QIAGEN NV | Equity | 1.50% | $13M | 378,072 | NL |
| 30 | INSMInsmed, Inc. | Equity | 1.44% | $13M | 92,576 | US |
| 31 | CERTCertara, Inc. Common Stock | Equity | 1.40% | $12M | 1,991,842 | US |
| 32 | NTRANatera, Inc. Common Stock | Equity | 1.34% | $12M | 56,770 | US |
| 33 | ILMNIllumina Inc | Equity | 1.34% | $12M | 92,110 | US |
| 34 | HSICHenry Schein Inc | Equity | 1.31% | $11M | 154,050 | US |
| 35 | BMYBristol-Myers Squibb Co. | Equity | 1.30% | $11M | 187,197 | US |
| 36 | DGXQuest Diagnostics Inc. | Equity | 1.29% | $11M | 57,932 | US |
| 37 | RVTYRevvity, Inc. | Equity | 1.28% | $11M | 129,591 | US |
| 38 | STERIS PLC | Equity | 1.27% | $11M | 51,343 | IE |
| 39 | LHLabcorp Holdings Inc. | Equity | 1.25% | $11M | 42,553 | US |
| 40 | SRPTSarepta Therapeutics,, Inc. Common Stock | Equity | 1.25% | $11M | 521,760 | US |
| 41 | RMDResMed Inc. | Equity | 1.24% | $11M | 50,577 | US |
| 42 | GILDGilead Sciences Inc | Equity | 1.22% | $11M | 81,464 | US |
| 43 | MEDTRONIC PLC | Equity | 1.21% | $11M | 131,027 | IE |
| 44 | UNHUNITEDHEALTH GROUP INCORPORATED (Delaware) | Equity | 1.19% | $10M | 27,972 | US |
| 45 | COOThe Cooper Companies, Inc. Common Stock | Equity | 1.14% | $10.0M | 158,790 | US |
| 46 | GEHCGE HealthCare Technologies Inc. Common Stock | Equity | 1.11% | $9.7M | 159,504 | US |
| 47 | WATWaters Corp | Equity | 0.90% | $7.9M | 25,416 | US |
| 48 | ALGNAlign Technology Inc | Equity | 0.89% | $7.8M | 44,152 | US |
| 49 | LLYEli Lilly & Co. | Equity | 0.88% | $7.7M | 8,229 | US |
| 50 | AAgilent Technologies Inc. | Equity | 0.88% | $7.7M | 66,406 | US |
| 51 | NBIXNeurocrine Biosciences Inc | Equity | 0.87% | $7.6M | 57,454 | US |
| 52 | MDLNMedline Inc. Class A common stock | Equity | 0.87% | $7.6M | 170,089 | US |
| 53 | HALOHalozyme Therapeutics, Inc. | Equity | 0.85% | $7.5M | 117,113 | US |
| 54 | TMOThermo Fisher Scientific, Inc. | Equity | 0.84% | $7.4M | 15,398 | US |
| 55 | ZTSZOETIS INC. | Equity | 0.84% | $7.4M | 64,030 | US |
| 56 | BMRNBioMarin Pharmaceuticals Inc | Equity | 0.83% | $7.2M | 133,988 | US |
| 57 | JNJJohnson & Johnson | Equity | 0.81% | $7.1M | 30,965 | US |
| 58 | IQVIQVIA Holdings Inc. | Equity | 0.80% | $7.0M | 44,382 | US |
| 59 | ABTAbbott Laboratories | Equity | 0.77% | $6.7M | 73,722 | US |
| 60 | MEDPMedpace Holdings, Inc. Common Stock | Equity | 0.75% | $6.6M | 15,763 | US |
| 61 | WSTWest Pharmaceutical Services, Inc. | Equity | 0.48% | $4.2M | 14,155 | US |
| 62 | SHCSotera Health Company Common Stock | Equity | 0.44% | $3.8M | 247,418 | US |
| 63 | ROYALTY PHARMA PLC | Equity | 0.42% | $3.7M | 73,962 | GB |
| 64 | EWEdwards Lifesciences Corp | Equity | 0.42% | $3.7M | 44,305 | US |
| 65 | NVSTEnvista Holdings Corporation Common stock, $0.01 par value per share | Equity | 0.41% | $3.6M | 139,849 | US |
| 66 | IDXXIdexx Laboratories Inc | Equity | 0.41% | $3.5M | 6,315 | US |
| 67 | ISRGIntuitive Surgical Inc. | Equity | 0.40% | $3.5M | 7,697 | US |
| 68 | ABBVABBVIE INC. | Equity | 0.39% | $3.4M | 16,313 | US |
| 69 | SYKStryker Corporation | Equity | 0.39% | $3.4M | 10,798 | US |
| 70 | VKTXViking Therapeutics, Inc | Equity | 0.39% | $3.4M | 109,034 | US |
| 71 | VRTXVertex Pharmaceuticals Inc | Equity | 0.39% | $3.4M | 7,945 | US |
| 72 | DXCMDexCom, Inc. | Equity | 0.38% | $3.4M | 56,496 | US |
| 73 | DHRDanaher Corporation | Equity | 0.38% | $3.3M | 18,713 | US |
| 74 | ALNYAlnylam Pharmaceuticals, Inc. | Equity | 0.38% | $3.3M | 10,723 | US |
| 75 | BSXBoston Scientific Corp. | Equity | 0.37% | $3.3M | 56,542 | US |
| 76 | VEEVVeeva Systems Inc. | Equity | 0.36% | $3.2M | 20,198 | US |
| 77 | MORGAN STANLEY INSTITUTIONAL LIQUIDITY FUNDS | Cash | 0.05% | $401K | 401,018 | US |
| 78 | DAIWA CAPITAL MARKETS AMERICA INC. | Cash | 0.00% | $13 | 13 | US |
Find which other funds hold a stock by opening it and choosing "ETFs holding".
Position changes between reports
| Action | Holding | Weight before | Weight after | Shares vs flows | Between reports |
|---|---|---|---|---|---|
| Increase | HUMHUMANA INC | 0.68% | 2.95% | +285.6% | Jan 31, 2026 → Apr 30, 2026 SEC |
| New position | DVADAVITA INC | — | 2.19% | — | Jan 31, 2026 → Apr 30, 2026 SEC |
| New position | BIOBIO-RAD LABORATORIES INC | — | 2.18% | — | Jan 31, 2026 → Apr 30, 2026 SEC |
| Exit | ACHCAcadia Healthcare Co Inc | 2.10% | — | — | Jan 31, 2026 → Apr 30, 2026 SEC |
| Exit | Perrigo Co PLC | 1.81% | — | — | Jan 31, 2026 → Apr 30, 2026 SEC |
| New position | CORMASIMO CORP | — | 1.74% | — | Jan 31, 2026 → Apr 30, 2026 SEC |
| Exit | RGENRepligen Corp | 1.62% | — | — | Jan 31, 2026 → Apr 30, 2026 SEC |
| Exit | APLSApellis Pharmaceuticals Inc | 1.60% | — | — | Jan 31, 2026 → Apr 30, 2026 SEC |
| Decrease | MEDPMEDPACE HOLDINGS INC | 2.30% | 0.75% | −51.1% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Decrease | SHCSOTERA HEALTH COMPANY | 1.82% | 0.44% | −69.9% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Decrease | IDXXIDEXX LABORATORIES INC | 1.76% | 0.41% | −70.5% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Decrease | LLYELI LILLY & COMPANY | 2.14% | 0.88% | −51.2% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | ELVELEVANCE HEALTH INC | 1.75% | 2.78% | +56.3% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | EXELEXELIXIS INC | 1.26% | 2.24% | +77.9% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Decrease | NTRANATERA INC | 2.24% | 1.34% | −28.2% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | GMEDGLOBUS MEDICAL INC | 1.38% | 2.27% | +76.4% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | ILMNILLUMINA INC | 0.46% | 1.34% | +255.6% | Jan 31, 2026 → Apr 30, 2026 SEC |
| New position | MDLNMEDLINE INC | — | 0.87% | — | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | STERIS PLC | 0.43% | 1.27% | +283.1% | Jan 31, 2026 → Apr 30, 2026 SEC |
| New position | IQVIQVIA HOLDINGS INC | — | 0.80% | — | Jan 31, 2026 → Apr 30, 2026 SEC |
| Decrease | ABTABBOTT LABORATORIES | 1.55% | 0.77% | −36.3% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Decrease | ISRGINTUITIVE SURGICAL INC | 1.19% | 0.40% | −59.9% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Decrease | ALNYALNYLAM PHARMACEUTICALS INC | 1.13% | 0.38% | −60.8% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | COOCOOPER COMPANIES INC (THE) | 0.41% | 1.14% | +283.1% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Decrease | PFEPFIZER INC | 2.36% | 1.65% | −25.9% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | BDXBECTON DICKINSON & COMPANY | 0.93% | 1.64% | +157.8% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | CHECHEMED CORP | 1.33% | 1.95% | +57.7% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | EHCENCOMPASS HEALTH CORP | 1.19% | 1.79% | +52.8% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Decrease | IONSIONIS PHARMACEUTICALS INC | 2.32% | 1.72% | −12.0% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | CICIGNA GROUP (THE) | 1.77% | 2.36% | +34.7% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Decrease | HALOHALOZYME THERAPEUTICS INC | 1.42% | 0.85% | −27.5% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Decrease | INSMINSMED INC | 2.00% | 1.44% | −11.1% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Decrease | VRTXVERTEX PHARMACEUTICALS INC | 0.92% | 0.39% | −50.3% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | CERTCERTARA INC | 0.89% | 1.40% | +142.1% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Decrease | ABBVABBVIE INC | 0.87% | 0.39% | −48.6% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | AAGILENT TECHNOLOGIES INC | 0.41% | 0.88% | +165.9% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Exit | ELANElanco Animal Health Inc | 0.44% | — | — | Jan 31, 2026 → Apr 30, 2026 SEC |
| Decrease | BMRNBIOMARIN PHARMACEUTICAL INC | 1.27% | 0.83% | −26.8% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Exit | BAXBaxter International Inc | 0.44% | — | — | Jan 31, 2026 → Apr 30, 2026 SEC |
| Decrease | SRPTSAREPTA THERAPEUTICS INC | 1.68% | 1.25% | −22.5% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | TMOTHERMO FISHER SCIENTIFIC INC | 0.42% | 0.84% | +162.6% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | HSICHENRY SCHEIN INC | 0.89% | 1.31% | +60.6% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Exit | TEMTempus AI Inc | 0.42% | — | — | Jan 31, 2026 → Apr 30, 2026 SEC |
| New position | NVSTENVISTA HOLDINGS CORP | — | 0.41% | — | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | UNHUNITEDHEALTH GROUP INC | 0.77% | 1.19% | +27.4% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Decrease | NBIXNEUROCRINE BIOSCIENCES INC | 1.28% | 0.87% | −25.1% | Jan 31, 2026 → Apr 30, 2026 SEC |
| New position | SYKSTRYKER CORP | — | 0.39% | — | Jan 31, 2026 → Apr 30, 2026 SEC |
| New position | DXCMDEXCOM INC | — | 0.38% | — | Jan 31, 2026 → Apr 30, 2026 SEC |
| New position | DHRDANAHER CORP | — | 0.38% | — | Jan 31, 2026 → Apr 30, 2026 SEC |
| Exit | PODDInsulet Corp | 0.37% | — | — | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | THCTENET HEALTHCARE CORP | 1.27% | 1.63% | +46.6% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Exit | INSPInspire Medical Systems Inc | 0.34% | — | — | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | RVTYREVVITY INC | 1.00% | 1.28% | +73.0% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | RMDRESMED INC | 0.95% | 1.24% | +68.1% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | REGNREGENERON PHARMACEUTICALS INC | 1.71% | 1.98% | +30.4% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | MEDTRONIC PLC | 0.95% | 1.21% | +73.7% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | ZBHZIMMER BIOMET HOLDINGS INC | 1.72% | 1.97% | +29.8% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Decrease | JNJJOHNSON & JOHNSON | 0.98% | 0.81% | −11.6% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | WSTWEST PHARMACEUTICAL SERVICES INC | 0.35% | 0.48% | +14.6% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | QIAGEN NV | 1.59% | 1.50% | +56.6% | Jan 31, 2026 → Apr 30, 2026 SEC |
Share-count changes are measured after removing what creations and redemptions explain.
Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.